 - Patients with platinum refractory epithelial ovarian cancer: Defined as those patients with histologically confirmed epithelial ovarian cancer that have not responded progressive or stable disease as a best response to an initial chemotherapy regimen that included a platinum agent cisplatin or carboplatin. 